KYOTO, Japan--(BUSINESS WIRE)--Reinforcing its commitment to researchers and clinicians, GE Healthcare, a unit of General Electric Company (NYSE:GE) is showcasing a comprehensive molecular imaging portfolio—encompassing tracer development, pre-clinical imaging and highly advanced imaging equipment— to provide insight into the origins of disease, at the World Molecular Imaging Congress (WMIC), Booth #212, September 8 through 11 in Kyoto, Japan.
